Zelton Dave SHARP,Carolina LIVI,Paul HASTY,Randy STRONG
申请号：
US14775337
公开号：
US20160015691A1
申请日:
2014.03.14
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Disclosed are methods and compositions for the prevention or inhibition of the growth of endocrine-related adenomas, neoplasia, or dysplasia in a patient who has been identified as being at risk for developing an endocrine tumor or endocrine cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
